Inventor · disambiguated record
Richard Wilde
Also filed as: WILDE RICHARD · WILDE RICHARD G · WILDE RICHARD GERALD
40 granted patents·12 pending applications·572 citations·filing 1992–2021
98Inventor score
Files withPTC THERAPEUTICS INC22BRISTOL MYERS SQUIBB PHARMA CO8DU PONT MERCK PHARMA7ALMSTEAD NEIL3CHOI SOONGYU2
Top patents by PatentIndex Score
52 records- 0194US7405233B2Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Jul 29, 2008·27 cites·2 claims
- 0293US7868037B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2006·Granted Jan 11, 2011·18 cites·31 claims
- 0391US5364875AImidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Nov 15, 1994·50 cites·13 claims
- 0490US7781478B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 24, 2010·8 cites·7 claims
- 0590US5583147AAmides for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1994·Granted Dec 10, 1996·49 cites·33 claims
- 0689US9919998B2Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamidesUNIV RUTGERS·Filed 2015·Granted Mar 20, 2018·9 cites·23 claims
- 0789US7772271B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 10, 2010·8 cites·7 claims
- 0889US6589952B2Imidazo[1,2-a]pyrazines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 8, 2003·30 cites·22 claims
- 0989US5310748AImidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted May 10, 1994·45 cites·9 claims
- 1088US5491152ADerivatives of cyclic ethers and sulfides for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1994·Granted Feb 13, 1996·40 cites·15 claims
- 1187US7973069B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2010·Granted Jul 5, 2011·5 cites·9 claims
- 1286US9289398B2Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewithALMSTEAD NEIL·Filed 2007·Granted Mar 22, 2016·9 cites·6 claims
- 1386US6642230B2Imidazopyrimidines and imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Nov 4, 2003·22 cites·5 claims
- 1485US6399609B1Therapeutic usage of tetrahydropteridines and pyridylpiperazines for treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jun 4, 2002·19 cites·4 claims
- 1584US5358946AHeterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Oct 25, 1994·28 cites·12 claims
- 1682US6869955B2Tetrahydropteridines and pyridylpiperazines for treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 22, 2005·14 cites·6 claims
- 1781US10370371B2Substituted pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Aug 6, 2019·3 cites·7 claims
- 1881US6143743AImidazopyrimidines and imidazopyridines for the treatment of neurological disordersDU PONT PHARM CO·Filed 1998·Granted Nov 7, 2000·41 cites·8 claims
- 1980US10428050B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Oct 1, 2019·4 cites·8 claims
- 2079US8013006B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2005·Granted Sep 6, 2011·5 cites·14 claims
- 2178US11180483B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·1 cites·16 claims
- 2278US6083948ATetrahydropteridines for treatment of neurological disordersDU PONT PHARM CO·Filed 1997·Granted Jul 4, 2000·36 cites·8 claims
- 2377US7902241B2Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2008·Granted Mar 8, 2011·2 cites·13 claims
- 2476US9611230B21,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of diseaseALMSTEAD NEIL G·Filed 2005·Granted Apr 4, 2017·1 cites·3 claims
- 2575US9315467B2Compounds for nonsense suppression, and methods for their useALMSTEAD NEIL·Filed 2005·Granted Apr 19, 2016·1 cites·8 claims
- 2675US6958341B2Pyrazolopyrimidines as CRF antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Oct 25, 2005·8 cites·11 claims
- 2775US5290801ABenzimidazoles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Mar 1, 1994·56 cites·8 claims
- 2874US7449570B2Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseasesPTC THERAPEUTICS INC·Filed 2005·Granted Nov 11, 2008·2 cites·18 claims
- 2971US10584115B2Substituted pyridine and pyrazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2020·1 cites·17 claims
- 3070US2022064150A1Substituted reverse pyrimidine bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3169US7045529B2Imidazopyrimidinyl and imidazopyri dinyl derivativesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 16, 2006·4 cites·21 claims
- 3268US7291603B2Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutationsPTC THERAPEUTICS INC·Filed 2003·Granted Nov 6, 2007·3 cites·15 claims
- 3365US2017204073A1Compounds for nonsense suppression, and methods for their usePTC THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3464US5478830AFused-ring heterocycles for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1992·Granted Dec 26, 1995·9 cites·12 claims
- 3562US2016229818A1Compounds for Nonsense Suppression, and Methods for Their UsePTC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3661US6362180B1Imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Mar 26, 2002·14 cites·2 claims
- 3760US9051342B2Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseasesALMSTEAD NEIL·Filed 2005·Granted Jun 9, 2015·0 cites·4 claims
- 3859US2015274674A1Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseasesPTC THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3957US7763656B2Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2007·Granted Jul 27, 2010·0 cites·20 claims
- 4056US2010069380A1Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereofCHOI SOONGYU·Filed 2007·Application pending·0 cites
- 4156US2008090774A1Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutationsPTC THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4256US2011268698A1Methods for treating hepatitis cPTC THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 4353US6960583B2Pyrazolotriazines as CRF antagonistsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 1, 2005·0 cites·8 claims
- 4452US7247741B2Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of diseaseAMGEN INC·Filed 2005·Granted Jul 24, 2007·0 cites·9 claims
- 4551US2011130397A1Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereofCHOI SOONGYU·Filed 2007·Application pending·0 cites
- 4650US2003220342A1Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndromeFiled 2003·Application pending·0 cites
- 4749US2010305100A1Methods for treating hepatitis cPTC THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4848US7026317B2Pyrazolotriazines as CRF antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 11, 2006·0 cites·8 claims
- 4946US8334313B2Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of diseaseWILDE RICHARD G·Filed 2010·Granted Dec 18, 2012·0 cites·15 claims
- 5044US2016199357A1Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewithPTC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →